-
Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate.
Cell Death Dis. 2013;4:e636
Authors: Santos-Carvalho A, Elvas F, Alvaro AR, Ambrósio AF, Cavadas C
PMID: 23681231 [PubMed - in process]
Read More about Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate. -
Ocular disease, knowledge and technology applications in patients with diabetes.
Am J Med Sci. 2013 Apr;345(4):266-70
Authors: Threatt J, Williamson JF, Huynh K, Davis RM
PMID: 23531956 [PubMed - indexed for MEDLINE]
Read More about Ocular disease, knowledge and technology applications in patients with diabetes. -
Corticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal disease.
Curr Opin Ophthalmol. 2013 May;24(3):248-54
Authors: Comyn O, Lightman SL, Hykin PG
PMID: 23518614 [PubMed - indexed for MEDLINE]
Read More about Corticosteroid intravitreal implants vs. ranibizumab for the treatment of vitreoretinal disease. -
Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease.
Vis Neurosci. 2012 Nov;29(6):267-74
Authors: Samuels IS, Lee CA, Petrash JM, Peachey NS, Kern TS
PMID: 23101909 [PubMed - indexed for MEDLINE]
Read More about Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease. -
Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial.
Diabet Med. 2013 Jan;30(1):95-9
Authors: Maple-Brown LJ, Ye C, Retnakaran R
PMID: 22937915 [PubMed - indexed for MEDLINE]
Read More about Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial. -
Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.
Diabet Med. 2012 Dec;29(12):1562-6
Authors: Rodríguez-Segade S, RodrÃguez J, GarcÃa López JM, Casanueva FF, Camiña F
PMID: 22913483 [PubMed - indexed for MEDLINE]
Read More about Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes. -
Should diabetes retinal screening intervals change?
Diabet Med. 2013 Jan;30(1):43-5
Authors: Leese GP
PMID: 22823411 [PubMed - indexed for MEDLINE]
Read More about Should diabetes retinal screening intervals change?
Comments
No comments have been submitted for this topic.